NL0:FRA
Grail Inc
€65.32
arrow_downward
-1.72%(-1.14) 1D
Sep 10, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NL0...
Open
€65.32
High
€65.32
Low
€65.32
Mkt. cap
3.46B
Avg. vol.
4.00
Volume
0.00
52-wk high
€97.80
52-wk low
€30.10
No. of employees
910
Open
€65.32
High
€65.32
Low
€65.32
Mkt. cap
3.46B
Avg. vol.
4.00
Volume
0.00
52-wk high
€97.80
52-wk low
€30.10
No. of employees
910
News stories
From web sources and news partners
Profile
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024. Wikipedia
About Grail Inc
CEO-
Employees910
Founded2015
HeadquartersMenlo Park, California, United States
SectorBiotechnology
Websitegrail.com